Treatment delay in breast cancer; does it really have an impact on prognosis?

Turkish Journal of Cancer

Volumn 32, Issue 4, 2002, Pages 138-147

  Samur, Mustafa ^a   Bozcuk, Hakan S ^a   Dalmaz, Gamze ^a   Karaveli, Şeyda ^a   Gül Köseoǧlu, Funda ^a   Çolak, Taner ^a   Pestereli, Elif ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Breast cancer; Treatment delay

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; CYCLOPHOSPHAMIDE; DOXORUBICIN; ESTROGEN RECEPTOR; ETOPOSIDE; FLUOROURACIL; METHOTREXATE; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER THERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; MULTIMODALITY CANCER THERAPY; PROGNOSIS; THERAPY DELAY; TREATMENT OUTCOME;

EID: 0041857799     PISSN: 10193103     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Caplan LS, Helzlsouer KJ. Delay in breast cancer: a review of the literature. Public Health Rev 1992-93;20:187-214.
2. Bedell MB, Wood ME, Lezotte DC, et al. Delay in diagnosis and treatment of breast cancer: implications for education. J Cancer Educ 1995;10:223-8.
3. Jenner DC, Middleton A, Webb WM, et al. In-hospital delay in the diagnosis of breast cancer. Br J Surg 2000;87:914-9.
4. Thongsuksai P, Chongsuvivatwong V, Sriplung H. Delay in breast cancer care: a study in Thai women. Med Care 2000;38:108-14.
5. Hebert-Croteau N, Freeman CR, Latreille J, et al. Delay in adjuvant radiation treatment and outcomes of breast cancer - a review. Breast Cancer Res Treat 2002;74:77-94.
6. Arndt V, Sturmer T, Stegmaier C, et al. Patient delay and stage of diagnosis among breast cancer patients in Germany - a population based study. Br J Cancer 2002;86:1034-40.
7. Olivotto IA, Gomi A, Bancej C, et al. Influence of delay to diagnosis on prognostic indicators of screen-detected breast carcinoma. Cancer 2002;94:2143-50.
8. Richards MA, Westcombe AM, Love SB, et al. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet 1999;353:1119-26.
9. Bozcuk H, Martin C. Does treatment delay effect survival in non-small cell lung cancer? A retrospective analysis from a single UK centre. Lung Cancer 2001;34:243-52.
10. Richards MA, Smith P, Raminwz AJ, et al. The influence on survival of delay in the presentation and the treatment of symptomatic breast cancer. Br J Cancer 1999;79:858-64.
11. Dennis CR, Gardner B, Lim B. Analysis of survival and recurrence vs. patient and doctor delay in treatment of breast cancer. Cancer 1975;35:714-20.
12. Charlson ME. Delay in the treatment of carcinoma of breast. Surg Gynecol Obstet 1985;160:393-9.
13. Toi M, Nakamura T, Wada T, et al. The acceptable delay between biopsy and radical mastectomy in breast cancer patients. Jpn J Surg 1989;19:679-83.
14. Afzelius P, Zedeler K, Sommer H, et al. Patient's and doctor's delay in primary breast cancer. Prognostic implications. Acta Oncol 1994;33:345-51.
15. Skipper HE. Kinetics of mammary tumor cell growth and implications for therapy. Cancer 1971;28:1479-99.
16. Skipper HE. Tumor differences, drug differences, treatment design differences and effects on therapeutic outcome (degree and duration of therapeutic response). Prog Clin Biol Res 1990;354A:81-98.
17. Buzdar AU, Smith TL, Marcus CE, et al. Significance of drug dose, timing and radiotherapy in adjuvant therapy of breast cancer. Recent Results Cancer Res 1984;96:141-7.
18. Pronzato P, Campora E, Amoroso D, et al. Impact of administration-related factors on outcome of adjuvant chemotherapy for primary breast cancer. Am J Clin Oncol 1989;12:481-5.